Search clinical trials for: Relapsed/Refractory Hodgkin Lymphoma

Total 10839 results

Anders Perner
Rigshospitalet, Denmark; University of Copenhagen; B. Braun Melsungen AG; Copenhagen...

Completed

Scandinavian Starch for Severe Sepsis/Septic Shock Trial (6S)

Septic Shock | Severe Sepsis

Denmark, Norway, Finland, Iceland
Peter Daley
Dalhousie University

Completed

A Clinical Trial to Study the Effect of the Addition of Vitamin D to Conventional Treatment in New Pulmonary Tuberculosis Patients

Pulmonary Tuberculosis

India
The University of Texas Health Science Center at...
National Cancer Institute (NCI)

Completed

Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer

Colorectal Cancer

United States
Steven E. Coutre

Completed

Monoclonal Antibody (mAb) 216 With Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia

Leukemia | Acute Lymphocytic Leukemia | Leukemia, Lymphocytic

United States
European Organisation for Research and Treatment...

Completed

Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis

Infection | Pulmonary Complications

France, Spain, Switzerland, Australia, Sweden, Luxembourg, Belgium, Germany, United Kingdom, Hungary, Italy, Israel, Ireland, Netherlands, United States
European Organisation for Research and Treatment...
University of Glasgow

Completed

Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma

Lymphoma

United Kingdom
European Organisation for Research and Treatment...

Completed

Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Colorectal Cancer

France, Belgium, Italy, Germany, Norway, Canada, Portugal, Greece, Austria
Emory University
Bayer

Terminated

Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab

Lymphoma

United States
Tufts Medical Center
University of Minnesota

Completed

Human Leukocyte Antigen (HLA) Class I Haplotype Mismatched Natural Killer Cell Infusions

Lymphoma | Leukemia | Myeloma

United States
St Stephens Aids Trust

Unknown

Evolution of Cellular and Viral Resistance in HIV-infected Patients With Lymphoma (SSAT042)

Lymphoma | HIV

United Kingdom
Northwestern University
National Cancer Institute (NCI)

Completed

Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery

Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Small Intestine Cancer | Ovarian Cancer | Peritoneal Cavity Cancer | Gastrointestinal Stromal Tumor | Extrahepatic Bile Duct Cancer | Nausea and Vomiting | Constipation, Impaction, and Bowel Obstruction

United States
Northwestern University
National Cancer Institute (NCI)

Completed

Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction

Quality of Life | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Small Intestine Cancer | Gastrointestinal Stromal Tumor | Extrahepatic Bile Duct Cancer | Constipation, Impaction, and Bowel Obstruction | Gastrointestinal Carcinoid Tumor

United States
Northwestern University
National Cancer Institute (NCI)

Completed

Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction

Quality of Life | Gastric Cancer | Colorectal Cancer | Small Intestine Cancer | Gastrointestinal Stromal Tumor | Constipation, Impaction, and Bowel Obstruction | Gastrointestinal Carcinoid Tumor

United States
Swiss Group for Clinical Cancer Research

Completed

Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Colorectal Cancer

Switzerland
Tehran University of Medical Sciences

Unknown

Unrelated Double Umbilical Cord Blood Units Transplantation

Leukemia, Myeloid, Acute | Leukemia, Lymphoblastic, Acute | Leukemia, Myeloid, Chronic

Iran, Islamic Republic of
OHSU Knight Cancer Institute
National Cancer Institute (NCI); medac GmbH

Completed

Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia

United States
Memorial Sloan Kettering Cancer Center

Completed

International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients

Lymphoma | Breast Cancer

United States
Rigshospitalet, Denmark
Dana-Farber Cancer Institute; St. Jude Children's Research Hospital; European... and other collaborators

Completed

Second Malignant Neoplasms After Childhood ALL Therapy (PdL-SMN1)

Acute Lymphoblastic Leukemia

Denmark
Samsung Medical Center

Completed

High-Dose (HD) Methotrexate (MTX) Induction Chemotherapy Followed by Alternative HD MTX-based and HD Cytarabine-based Combination Consolidation Chemotherapy for Newly Diagnosed Primary CNS Lymphoma; CISL 10-01 Study

CNS Lymphoma

Korea, Republic of
Samsung Medical Center

Completed

Samsung Medical Center-Lymphoma Cohort Study (SMC-LCS)

Lymphoma

Korea, Republic of
Queensland Institute of Medical Research
National Health and Medical Research Council, Australia; Australian Department... and other collaborators

Completed

Epstein-Barr Virus (EBV)-Specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas (EPL)

Lymphoma

Australia
Esanex Inc.
National Cancer Institute (NCI)

Completed

Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And Lymphomas

Lymphoma | Leukemia | Solid Tumor Malignancy | Lymphoid Malignancy (Lymphoma and CLL)

United States
Veeda Oncology
Eli Lilly and Company; Sanofi; Genentech, Inc.

Completed

A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC

Non-Small Cell Lung Cancer

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer

Head and Neck Cancer

United States
Peter MacCallum Cancer Centre, Australia
The Leukemia and Lymphoma Society

Completed

A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone

Lymphoma | Multiple Myeloma

Australia
Otsuka Pharmaceutical Development & Commercialization...

Completed

Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure

Heart Failure, Congestive

United States, Romania
Novartis Pharmaceuticals

Completed

A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589

Cancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological Malignancies

United States
Central European Cooperative Oncology Group

Completed

Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Israel, Turkey, Croatia, Portugal, Austria, Bulgaria, Hungary, Romania, Slovakia, Slovenia, Bosnia and Herzegovina, Cyprus, Czech Republic
Nestlé
University Hospital Inselspital, Berne; University of Bern

Completed

Effect of β-alanine Supplementation on Muscle Carnosine (LitmusMagnet)

Healthy

Switzerland
Phoenix Children's Hospital
Jazz Pharmaceuticals; Fisher Bioservices

No longer available

Erwinase Master Treatment Protocol (EMTP)

Acute Lymphoid Leukemia | Leukemia, Acute Lymphoblastic
Chelsea and Westminster NHS Foundation Trust
HIV in Europe (Co-Sponsor)

Unknown

HIV Indicator Diseases Survey Across Europe - UK Arm

HIV | AIDS | Indicator Diseases/Indicator Conditions

United Kingdom
Keio University

Completed

Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies

Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia

Japan
Duke University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Umbilical Cord Blood Stem Cell Transplantation in Adults With Advanced Blood Disorders or Cancer

Hematologic Neoplasms

United States
Sixth Affiliated Hospital, Sun Yat-sen University

Unknown

Efficacy and Safety Study of a Modified XELOX Regimen in First-Line Treatment of Metastatic Colorectal Adenocarcinoma (mXELOX)

Colorectal Adenocarcinoma

China
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Withdrawn

Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia

Leukemia

United States, India
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Withdrawn

Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Lymphoma

United States
ZARS Pharma Inc.

Completed

Study Evaluating Heated Lidocaine/Tetracaine Patch in Patients With Pain Associated With Myofascial Trigger Points

Myofascial Pain Syndromes

United States
Rabin Medical Center

Unknown

Telomerase Activity as a Marker For Mobilization Quality

Lymphoma | Multiple Myeloma

Israel
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis

Lymphoma | Leukemia | Chronic Myeloproliferative Disorders | Precancerous Condition | Nonneoplastic Condition

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer

Lymphoma | Leukemia | Unspecified Adult Solid Tumor, Protocol Specific

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Diseases | Graft Versus Host Disease

United States
Novartis Pharmaceuticals

Terminated

Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders.

Chronic Myeloid Leukemia (CML) | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) | Other Glivec/Gleevec Indicated Hematological Disorders (HES, CEL, MDS/ MPN)

Russian Federation
University of Miami
American Cancer Society, Inc.

Completed

Assessing the Effectiveness of Individual Education Plans for Childhood Cancer Survivors

Lymphoma | Acute Lymphoblastic Leukemia | Central Nervous System Tumors

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Cognitive Functioning and Quality of Life in CNS Lymphoma

Lymphoma | Central Nervous System Lymphoma

United States
St. Joseph's Healthcare Hamilton
McMaster University

Completed

A Trial of Vitamin D and Health Advice for the Prevention of Upper Respiratory Tract Infections

Infections | Upper Respiratory Tract Infections | Rhinovirus

Canada
M.D. Anderson Cancer Center

Completed

Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support

Hematologic Malignancies

United States
M.D. Anderson Cancer Center

Withdrawn

Molecular Epidemiology of Lymphoma Patients

Lymphoma
Helse Stavanger HF
University of Oslo; University of Bergen; Pronova BioPharma; Pharmacia and Upjohn

Completed

Effects of High-dose n-3 Fatty Acids on Clinical Outcome and Serum Lipids - Omacor Following Acute Myocardial Infarction (OFAMI)

Myocardial Infarction | Coronary Disease

Norway
Fudan University

Completed

Rituximab Combined With ESHAP in Patients With Relapse or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Lymphoma

China
M.D. Anderson Cancer Center
Enzon Pharmaceuticals, Inc.

Completed

Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage

Acute Lymphoblastic Leukemia

United States

Search clinical trials for: Relapsed/Refractory Hodgkin Lymphoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations